赤藓糖醇过剩改善，代糖股业绩回暖，新代糖又现扩产潮

Core Viewpoint - The new round of expansion in the sugar substitute industry is emerging, driven by the recovery of erythritol supply and the introduction of new sugar substitutes like allulose [1] Group 1: Erythritol Market Recovery - The financial reports of companies such as Sanyuan Biological and Baolingbao indicate a recovery in performance, attributed to the improvement in the erythritol market in 2024 [2] - Sanyuan Biological reported total revenue of 710 million yuan, a year-on-year increase of 42.7%, and a net profit of 110 million yuan, up 87.5% [2] - Baolingbao's total revenue for 2024 was 2.4 billion yuan, a decrease of 4.8%, but its net profit increased by 106% [2] - The revenue from erythritol for Sanyuan Biological reached 520 million yuan, a growth of 26.4%, with gross margin rising from 1.1% in 2023 to 8.3% in 2024 [2] - Baolingbao's erythritol sales revenue grew by 52.6%, with a gross margin increase of 7.8 percentage points [2] Group 2: Industry Dynamics and Challenges - The competition in the erythritol industry is easing, but prices remain low, leading to potential closures or shifts in production among some companies [3] - The U.S. has initiated anti-dumping and countervailing investigations against Chinese erythritol products, adding uncertainty to exports [3] - Sanyuan Biological is exploring diversification in global markets, focusing on Southeast Asia, India, and regions along the Belt and Road [3] - Baolingbao plans to invest 620 million yuan in a functional sugar factory in the U.S. to meet growing international demand [3] Group 3: Allulose Development - Allulose, a new sugar substitute, is gaining attention due to its similar taste and texture to sucrose, low caloric content, and potential health benefits [4] - Allulose has been approved for use in over ten countries, and its approval as a new food ingredient in China is pending [4] - The market for sugar substitutes is expected to grow significantly, driven by health trends and innovation [4] Group 4: Production Capacity and Market Concerns - Allulose is currently being tested in beverages, with a production cost around 30,000 yuan per ton, while selling prices in Europe and the U.S. range from 30,000 to 40,000 yuan per ton [5] - The high price of allulose results in a higher gross margin compared to erythritol, with Sanyuan Biological's allulose gross margin at 14.2% [5] - Concerns exist regarding potential overproduction of allulose similar to erythritol, as companies are rapidly expanding capacity [6] - Baolong Chuangyuan plans to increase its allulose production capacity significantly, while Sanyuan Biological also has expansion plans [6]